{
    "clinical_study": {
        "@rank": "139609", 
        "arm_group": {
            "arm_group_label": "Adjuvant chemotherapy", 
            "description": "Subjects will undergo pain testing, then receive standard of care chemotherapy, and then undergo pain testing."
        }, 
        "brief_summary": {
            "textblock": "Many breast cancer survivors report chronic pain that develops or worsens following\n      chemotherapy. The impact of chemotherapy on the development of chronic pain is uncertain. In\n      this proposal, we are studying the impact of chemotherapy on a patient's sensitivity to\n      pain. We are also investigating whether a patient's sensitivity to pain is related to how\n      many symptoms she experiences during treatment."
        }, 
        "brief_title": "Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Breast Cancer", 
            "Chronic Pain"
        ], 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female gender\n\n          -  Histologically proven stage I-III invasive carcinoma of the breast who is planning to\n             receive a standard dose of adjuvant chemotherapy.\n\n          -  Surgical resection should be complete at the time of study enrollment.\n\n          -  Eastern Cooperative Oncology Group performance status 0-2.\n\n        Exclusion Criteria:\n\n          -  Average pain over the past 24 hours of 4 or greater on a 0-10 scale.\n\n          -  Peripheral sensory neuropathy grade 2 or higher.\n\n          -  Personal history of schizophrenia or major depressive disorder, or history of\n             suicidal ideation or attempt within the past 2 years.\n\n          -  Thumbnail abnormalities on either hand (such as artificial nails) that are likely to\n             alter pain perception during testing.\n\n          -  Pregnant or nursing.\n\n          -  No prior chemotherapy for any reason"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women initiating adjuvant chemotherapy to treat stage I-III breast cancer."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983982", 
            "org_study_id": "HUM00077174", 
            "secondary_id": "UMCC 2013.073"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast Cancer", 
            "Chemotherapy", 
            "Chronic Pain", 
            "Survivorship"
        ], 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "contact": {
                "email": "norahh@umich.edu", 
                "last_name": "Norah L Henry, MD, PhD", 
                "phone": "800-865-1125"
            }, 
            "facility": {
                "address": {
                    "city": "Ann Arbor", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48109"
                }, 
                "name": "University of Michigan Health System"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms in Early Stage Breast Cancer", 
        "overall_official": {
            "affiliation": "University of Michigan", 
            "last_name": "Norah L Henry, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Feasibility will be measured by the proportion of women who complete the post-chemotherapy assessment among those consenting to participate in the trial.", 
            "measure": "Feasibility of recruiting patients at chemotherapy initiation", 
            "safety_issue": "No", 
            "time_frame": "15 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983982"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Michigan", 
            "investigator_full_name": "N. Lynn Henry", 
            "investigator_title": "Assistant Professor of Internal Medicine, Medical School", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Patients will undergo quantitative sensory testing to identify change in pain threshold and in the magnitude of conditioned pain modulation before chemotherapy and shortly after the final dose of chemotherapy.", 
                "measure": "Change in Pain Sensitivity in Breast Cancer Patients Associated with Chemotherapy", 
                "safety_issue": "No", 
                "time_frame": "15 weeks"
            }, 
            {
                "description": "Exploratory analyses will be conducted to examine associations between either baseline or change in quantitative sensory testing measures and change in patient-reported outcomes.", 
                "measure": "Association Between Baseline Pain-Pressure Threshold and Development of Chemotherapy-associated Acute Pain", 
                "safety_issue": "No", 
                "time_frame": "15 weeks"
            }
        ], 
        "source": "University of Michigan", 
        "sponsors": {
            "collaborator": {
                "agency": "Damon Runyon Cancer Research Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Michigan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}